FibroBiologics Common Stock Statistics Share Statistics FibroBiologics Common Stock has 41.89M
shares outstanding. The number of shares has increased by 8.83%
in one year.
Shares Outstanding 41.89M Shares Change (YoY) 8.83% Shares Change (QoQ) 5.09% Owned by Institutions (%) 17.52% Shares Floating 32.07M Failed to Deliver (FTD) Shares 5,500 FTD / Avg. Volume 1%
Short Selling Information The latest short interest is 917.55K, so 2.22% of the outstanding
shares have been sold short.
Short Interest 917.55K Short % of Shares Out 2.22% Short % of Float 2.6% Short Ratio (days to cover) 2.19
Valuation Ratios The PE ratio is -5.89 and the forward
PE ratio is -0.99.
FibroBiologics Common Stock's PEG ratio is
0.14.
PE Ratio -5.89 Forward PE -0.99 PS Ratio 0 Forward PS n/a PB Ratio 24.04 P/FCF Ratio -5.44 PEG Ratio 0.14
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for FibroBiologics Common Stock.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.12,
with a Debt / Equity ratio of 3.86.
Current Ratio 1.12 Quick Ratio 1.12 Debt / Equity 3.86 Debt / EBITDA -0.77 Debt / FCF -0.87 Interest Coverage -686.85
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-858.54K Employee Count 13 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -78.18% in the
last 52 weeks. The beta is -0.71, so FibroBiologics Common Stock's
price volatility has been lower than the market average.
Beta -0.71 52-Week Price Change -78.18% 50-Day Moving Average 0.59 200-Day Moving Average 1.09 Relative Strength Index (RSI) 57.39 Average Volume (20 Days) 549,446
Income Statement
Revenue n/a Gross Profit -573K Operating Income -13.74M Net Income -11.16M EBITDA -13.74M EBIT -11.18M Earnings Per Share (EPS) -0.34
Full Income Statement Balance Sheet The company has 13.98M in cash and 10.55M in
debt, giving a net cash position of 3.43M.
Cash & Cash Equivalents 13.98M Total Debt 10.55M Net Cash 3.43M Retained Earnings -35.52M Total Assets 13.91M Working Capital -786K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -11.9M
and capital expenditures -184K, giving a free cash flow of -12.09M.
Operating Cash Flow -11.9M Capital Expenditures -184K Free Cash Flow -12.09M FCF Per Share -0.37
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
